Distinguished in Lung Metastases

Thomas K. Waddell

164 College Street, M5S 3G9, 
Toronto, ON, CA 
Distinguished in Lung Metastases
164 College Street, M5S 3G9, 
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Thomas Waddell practices in Toronto, Canada. Mr. Waddell is rated as a Distinguished expert by MediFind in the treatment of Lung Metastases. His top areas of expertise are Lung Cancer, Lung Metastases, Non-Small Cell Lung Cancer (NSCLC), Lung Transplant, and Endoscopy.

His clinical research consists of co-authoring 213 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles and participated in 1 clinical trial in the study of Lung Metastases.

Gender
Male

Locations

164 College Street, M5S 3G9, Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

The Role of Multimodality Management in Risk-Stratified Patients With Lung-Limited Metastatic Colorectal Cancer
The Role of Multimodality Management in Risk-Stratified Patients With Lung-Limited Metastatic Colorectal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 30, 2025
Intervention Type: Drug, Procedure
Study Drug: Chemotherapy
Study Phase: Phase 2
Phase II Study of Single Agent Pre-operative Metformin in Patients With Clinical Stage I - IIIA NSCLC Proceeding to Surgical Resection. 'Lung Metcore Study'
Phase II Study of Single Agent Pre-operative Metformin in Patients With Clinical Stage I - IIIA NSCLC Proceeding to Surgical Resection. 'Lung Metcore Study'
Enrollment Status: Completed
Publish Date: August 19, 2020
Intervention Type: Drug
Study Phase: Phase 2
Extended Low-Molecular Weight Heparin VTE Prophylaxis in the Thoracic Surgery Population, a Prospective, Randomized Controlled Study
Extended Low-Molecular Weight Heparin VTE Prophylaxis in the Thoracic Surgery Population, a Prospective, Randomized Controlled Study
Enrollment Status: Completed
Publish Date: September 18, 2018
Intervention Type: Drug, Other
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

212 Total Publications

1,000 Cases of Ex Vivo Lung Perfusion for Lung Transplantation: A Single Centre Experience.
1,000 Cases of Ex Vivo Lung Perfusion for Lung Transplantation: A Single Centre Experience.
Journal: The Journal of thoracic and cardiovascular surgery
Published: May 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Waddell's expertise for a condition
ConditionClose
View All 24 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile